Periodontitis and Systemic Diseases

24.American Diabetes Association. Glycemic targets: Standards of medical care in diabetes-2018. Diabetes Care 2018;41(Suppl 1):S55–S64.

25.Loe H. Periodontal disease: The sixth complication of diabetes mellitus. Diabetes Care 1993;16:329–334.

26.Jepsen S, Caton JG, Albandar JM, et al. Periodontal manifestations of systemic diseases and developmental and acquired conditions: Consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol 2018;45(Suppl 20):S219–S229.

27.Perlstein MI, Bissada NF. Influence of obesity and hypertension on the severity of periodontitis in rats. Oral Surgery Oral Med Oral Pathol 1977;43:707–719.

28.Saito T, Shimazaki Y, Sakamoto M. Obesity and periodontitis. N Engl J Med 1998;339:482–483.

29.Keller A, Rohde JF, Raymond K, Heitmann BL. Association between periodontal disease and overweight and obesity: a systematic review. J Periodontol 2015;86:766–776.

30.Moura-Grec PG, Marsicano JA, Carvalho CA, Sales-Peres SH. Obesity and periodontitis: systematic review and meta-analysis. Cien Saude Colet 2014;19:1763–1772.

31.Jimenez M, Hu FB, Marino M, Li Y, Joshipura KJ. Prospective associations between measures of adiposity and periodontal disease. Obesity 2012;20:1718–1725.

32.Gorman A, Kaye EK, Apovian C, Fung TT, Nunn M, Garcia RI. Overweight and obesity predict time to periodontal disease progression in men. J Clin Periodontol 2012;39:107–114.

33.Martinez-Herrera M, Silvestre-Rangil J, Silvestre F. Association between obesity and periodontal disease. A systematic review of epidemiological studies and controlled clinical trials. Med Oral Patol Oral Cir Bucal 2017;22: e708–e715.

34.Martinez-Herrera M, Silvestre FJ, Silvestre-Rangil J, Bañuls C, Rocha M, Hernández-Mijares A. Involvement of insulin resistance in normoglycaemic obese patients with periodontitis: a cross-sectional study. J Clin Periodontol 2017;44:981–988.

35.D’Aiuto F, Sabbah W, Netuveli G, et al. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab 2008;93:3989–3994.

36.Morita I, Okamoto Y, Yoshii S, et al. Five-year incidence of periodontal disease is related to body mass index. J Dent Res 2011;90:199–202.

37.Merchant AT, Pitiphat W, Rimm EB, Joshipura K. Increased physical activity decreases periodontitis risk in men. Eur J Epidemiol 2003;18:891–898.

38.Haffajee AD, Socransky SS. Relation of body mass index, periodontitis and Tannerella forsythia . J Clin Periodontol 2009;36:89–99.

39.Maciel SS, Feres M, Gonçalves TE, et al. Does obesity influence the subgingival microbiota composition in periodontal health and disease? J Clin Periodontol 2016;43: 1003–1012.

40.Suvan J, Petrie A, Moles DR, et al. Body mass index as a predictive factor of periodontal therapy outcomes. J Dent Res 2014;93:49–54.

41.Palomo L. BMI is a predictor of periodontal therapy outcomes. J Evid Based Dent Pract 2014;14:82–84.

42.Suvan JE, Finer N, D’Aiuto F. Periodontal complications with obesity. Periodontol 2000 2018;78:98–128.

43.International Diabetes Federation (IDF). IDF Diabetes Atlas, 7th edition. Brussels: International Diabetes Federation, 2015.

44.Unnikrishnan R, Pradeepa R, Joshi SR, Mohan V. Type 2 diabetes: Demystifying the global epidemic. Diabetes 2017;66:1432–1442.

45.Assah F, Mbanya JC. Diabetes in sub-Saharan Africa. In: Dagogo-Jack S (ed). Diabetes Mellitus in Developing Countries and Underserved Communities. Cham: Springer, 2016;33–48.

46.Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2014. Estimates of diabetes and its burden in the epidemiologic estimation methods. Washington: US Department of Health and Human Services, 2014.

47.Petersen M. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003;26:917–932.

48.Livingstone SJ, Levin D, Looker HC, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008–2010. JAMA 2015;313:37–44.

49.Williams RC Jr, Mahan CJ. Periodontal disease and diabetes in young adults. J Am Med Assoc 1960;172:776–778.

50.Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol 1998;3: 51–61.

51.Atkinson MA. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med 2012;2:a007641.

52.Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010;464:1293–1300.

53.Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 1986;35:990–998.

54.Skyler JS, Bakris GL, Bonifacio E, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes 2017;66:241–255.

55.Morris A, Voight B, Teslovich T. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012; 44:981–990.

56.Groop L, Forsblom C, Lehtovirta M, et al. Metabolic consequences of a family history of NIDDM (the Botnia study): Evidence for sex-specific parental effects. Diabetes 1996;45:1585–1593.

57.Hamalainen A.-M, Knip M. Autoimmunity and familial risk of type 1 diabetes. Curr Diab Rep 2002;2:347–353.

58.The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.

59.Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643–2653.

60.UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837–853.

61.Genuth S, Eastman R, Kahn R, et al. Implications of the United Kingdom prospective diabetes study. Diabetes Care 2003;26:S28–S32.

62.Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol 2001;6:99–112.

63.Meyle J, Chapple ILC. Molecular aspects of the pathogenesis of periodontitis. Periodontol 2000 2015;69:7–17.

64.Nelson RG, Shlossman M, Budding LM, et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990;13:836–840.

65.Cianciola LJ, Park BH, Bruck E, Mosovich L, Genco RJ. Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). J Am Dent Assoc 1982;104:653–660.

66.Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 1991;62:123–131.

67.Preshaw PM, Bissett SM. Periodontitis: oral complication of diabetes. Endocrinol Metab Clin North Am 2013;42: 849–867.

68.Apoorva SM, Sridhar N, Suchetha A. Prevalence and severity of periodontal disease in type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus) patients in Bangalore city: an epidemiological study. J Indian Soc Periodontol 2013;17:25–29.

69.Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002;30: 182–192.

70.Nascimento GG, Leite FRM, Vestergaard P, Scheutz F, Lopez R. Does diabetes increase the risk of periodontitis? A systematic review and meta-regression analysis of longitudinal prospective studies. Acta Diabetol 2018;55: 653–667.

71.Lee CY. Kuan YH, Tsai YF, Tai CJ, Tsai TH, Huang KH. Correlation between diabetes mellitus and periodontitis in Taiwan: A nationwide cohort study. Diabetes Res Clin Pract 2019;150:245–252.